Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CervALONE: CERVAVAC vs Gardasil HPV Vaccine Trial
NCT07256912Phase 4Active, not recruiting
- Sponsor
- International Agency for Research on Cancer
- Start
- Jun 2026
- Primary completion
- Dec 2028
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of CERVAVAC in human papillomavirus infection, sponsored by International Agency for Research on Cancer. Started Jun 2026; status: active, not recruiting.
02
Drugs
CERVAVAC
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT07256912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07256912.